David Roman
Stock Analyst at Goldman Sachs
(1.92)
# 3,168
Out of 5,157 analysts
65
Total ratings
37.84%
Success rate
-5.71%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $363 → $326 | $238.24 | +36.84% | 2 | Feb 19, 2026 | |
| BAX Baxter International | Maintains: Neutral | $21 → $17 | $17.46 | -2.63% | 5 | Feb 17, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $108 → $95 | $85.78 | +10.75% | 5 | Feb 11, 2026 | |
| DOCS Doximity | Maintains: Neutral | $46 → $34 | $24.78 | +37.21% | 5 | Feb 9, 2026 | |
| MDLN Medline | Initiates: Buy | $49 | $42.88 | +14.27% | 1 | Jan 12, 2026 | |
| HQY HealthEquity | Downgrades: Sell | $89 | $78.50 | +13.38% | 4 | Jan 9, 2026 | |
| KMTS Kestra Medical Technologies | Maintains: Neutral | $22 → $25 | $22.29 | +12.16% | 3 | Dec 15, 2025 | |
| COO The Cooper Companies | Maintains: Sell | $64 → $71 | $74.41 | -4.58% | 2 | Dec 8, 2025 | |
| MDT Medtronic | Upgrades: Neutral | $81 → $111 | $89.89 | +23.48% | 2 | Nov 19, 2025 | |
| IRTC iRhythm Holdings | Maintains: Neutral | $180 → $202 | $120.53 | +67.59% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $33 | $10.97 | +200.82% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $16 | $17.12 | -6.54% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $103 | $103.15 | -0.15% | 1 | Oct 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $13.05 | +53.26% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $11.80 | +61.02% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $29 | $14.25 | +103.51% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $104 | $91.70 | +13.41% | 2 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $5.57 | +79.53% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $94 → $82 | $72.73 | +12.75% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $154 | $110.55 | +39.30% | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $24 | $21.88 | +9.69% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $63 → $71 | $67.60 | +5.03% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $55 | $61.93 | -11.19% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $384 → $427 | $358.65 | +19.06% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $90 | $69.96 | +28.64% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $500 | $485.85 | +2.91% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $163.88 | +67.20% | 1 | May 30, 2024 |
Insulet
Feb 19, 2026
Maintains: Buy
Price Target: $363 → $326
Current: $238.24
Upside: +36.84%
Baxter International
Feb 17, 2026
Maintains: Neutral
Price Target: $21 → $17
Current: $17.46
Upside: -2.63%
Edwards Lifesciences
Feb 11, 2026
Maintains: Buy
Price Target: $108 → $95
Current: $85.78
Upside: +10.75%
Doximity
Feb 9, 2026
Maintains: Neutral
Price Target: $46 → $34
Current: $24.78
Upside: +37.21%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $49
Current: $42.88
Upside: +14.27%
HealthEquity
Jan 9, 2026
Downgrades: Sell
Price Target: $89
Current: $78.50
Upside: +13.38%
Kestra Medical Technologies
Dec 15, 2025
Maintains: Neutral
Price Target: $22 → $25
Current: $22.29
Upside: +12.16%
The Cooper Companies
Dec 8, 2025
Maintains: Sell
Price Target: $64 → $71
Current: $74.41
Upside: -4.58%
Medtronic
Nov 19, 2025
Upgrades: Neutral
Price Target: $81 → $111
Current: $89.89
Upside: +23.48%
iRhythm Holdings
Oct 31, 2025
Maintains: Neutral
Price Target: $180 → $202
Current: $120.53
Upside: +67.59%
Oct 29, 2025
Maintains: Buy
Price Target: $26 → $33
Current: $10.97
Upside: +200.82%
Oct 1, 2025
Initiates: Neutral
Price Target: $16
Current: $17.12
Upside: -6.54%
Oct 1, 2025
Initiates: Buy
Price Target: $103
Current: $103.15
Upside: -0.15%
Aug 25, 2025
Initiates: Buy
Price Target: $20
Current: $13.05
Upside: +53.26%
Aug 18, 2025
Initiates: Buy
Price Target: $19
Current: $11.80
Upside: +61.02%
Jul 1, 2025
Initiates: Buy
Price Target: $29
Current: $14.25
Upside: +103.51%
May 6, 2025
Maintains: Neutral
Price Target: $120 → $104
Current: $91.70
Upside: +13.41%
May 1, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.57
Upside: +79.53%
May 1, 2025
Maintains: Buy
Price Target: $94 → $82
Current: $72.73
Upside: +12.75%
Mar 4, 2025
Maintains: Buy
Price Target: $138 → $154
Current: $110.55
Upside: +39.30%
Mar 3, 2025
Maintains: Neutral
Price Target: $42 → $24
Current: $21.88
Upside: +9.69%
Mar 3, 2025
Maintains: Sell
Price Target: $63 → $71
Current: $67.60
Upside: +5.03%
Mar 3, 2025
Maintains: Buy
Price Target: $64 → $55
Current: $61.93
Upside: -11.19%
Jan 30, 2025
Maintains: Neutral
Price Target: $384 → $427
Current: $358.65
Upside: +19.06%
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $69.96
Upside: +28.64%
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $485.85
Upside: +2.91%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $163.88
Upside: +67.20%